Validation of in-vitro data by in-vivo evidence: the example of angiotensin (1-7).
Brunner
Hans R
HR
Gavras
Haralambos
H
D000803:Angiotensin I / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D051381:Rats; D012077:Renal Artery / Q000187:drug effects* / Q000502:physiology; D012079:Renal Circulation / Q000187:drug effects* / Q000502:physiology; D046509:Tissue Culture Techniques; D014655:Vascular Resistance / Q000187:drug effects
D000959:Antihypertensive Agents; D010446:Peptide Fragments; D000803:Angiotensin I; C118790:angiotensin I (1-7)